|
⚲
|
| Keyboard |
| Angion Biomedica Corp | |
|---|---|
| Ticker | ELTX |
| CIK # | 0001601485 |
| CUSIP | 28657F103 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 51 Charles Lindbergh Boulevard, Uniondale, NY 11553 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Elicio Therapeutics Inc | 2024-03-29 | 6.0 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| Angion Biomedica Corp | 2020-06-23 | 6.7 M | Exemption: 506(b) · Minimum: $25,000 · Remaining: $33,305,000 · Duration: One year or less · Commission: $4,000,000 · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001601485] | 10-K | |
| [0001601485] | 10-Q | |
| [0001601485] | 3 | |
| [0001601485] | 4 | |
| [0001601485] | 8-K | |
| [0001601485] | D | |
| [0001601485] | SC 13D | |
| [0001601485] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Shah Preetam
Common Stock
|
2026-02-02 | Grant | 24,000 | $0.00 | |
|
DeMuth Peter
Common Stock
|
2026-02-02 | Grant | 20,800 | $0.00 | |
|
Connelly Robert
Common Stock
|
2026-02-02 | Grant | 73,600 | $0.00 | |
|
Haqq Christopher
Common Stock
|
2026-02-02 | Grant | 25,400 | $0.00 | |
|
Connelly Robert
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 147,200 | $0.00 | |
|
Shah Preetam
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 47,900 | $0.00 | |
|
DeMuth Peter
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 41,600 | $0.00 | |
|
Haqq Christopher
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 50,900 | $0.00 | |
|
DeMuth Peter
Common Stock
|
2025-12-09 | Option exercise | 362 | $4.41 | 1,596 |
|
DeMuth Peter
Stock Option (Right to Buy) · derivative
|
2025-12-09 | Option exercise | 362 | $0.00 | |
|
Chudnovsky Yekaterina +1
Warrant (right to buy) · derivative
|
2025-06-03 | Grant | 103,225 | $0.00 | |
|
Ashe Carol Gail
Stock Option (Right to Buy) · derivative
|
2025-05-19 | Grant | 7,900 | $0.00 | |
|
Nissenson Allen
Stock Option (Right to Buy) · derivative
|
2025-05-19 | Grant | 7,900 | $0.00 | |
|
Venkatesan Jay
Stock Option (Right to Buy) · derivative
|
2025-05-19 | Grant | 7,900 | $0.00 | |
|
Adams Julian
Stock Option (Right to Buy) · derivative
|
2025-05-19 | Grant | 7,900 | $0.00 | |
|
Wilson Karen J
Stock Option (Right to Buy) · derivative
|
2025-05-19 | Grant | 7,900 | $0.00 | |
|
Ruffolo Robert R
Stock Option (Right to Buy) · derivative
|
2025-05-19 | Grant | 7,900 | $0.00 | |
|
Chudnovsky Yekaterina
Stock Option (Right to Buy) · derivative
|
2025-05-19 | Grant | 7,900 | $0.00 | |
|
Shah Preetam
Stock Option (Right to Buy) · derivative
|
2025-04-15 | Grant | 191,624 | $0.00 | |
|
Chudnovsky Yekaterina +1
Common Stock
|
2025-03-05 | Conversion | 3,500,573 | $5.81 | 20,338,329 |
| showing 20 of 160 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 49 | 3,110,920 |
| 2025-12-31 | 39 | 2,430,272 |
| 2025-09-30 | 30 | 2,052,273 |
| 2025-06-30 | 24 | 1,570,816 |
| 2025-03-31 | 25 | 1,591,744 |
| 2024-12-31 | 18 | 454,072 |
| 2024-09-30 | 19 | 491,491 |
| 2024-06-30 | 21 | 648,667 |
| 2024-03-31 | 19 | 406,639 |
| 2023-12-31 | 19 | 333,048 |
| 2023-09-30 | 19 | 330,985 |
| 2023-06-30 | 16 | 285,765 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Wealth Enhancement Advisory Services LLC | [2026-06-30] | SOLE | 6,743 | 11,972 |
| Moody Lynn Lieberson & Walker LLC | [2026-06-30] | SOLE | 10,000 | 10,000 |
| Mayflower Financial Advisors LLC | [2026-06-30] | SOLE | 0 | 10,000 |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 947 | Prev | Page 1 | Next |